Next Generation Cytopathology: Current Status and Future Prospects
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: closed (28 February 2025) | Viewed by 8992
Special Issue Editor
2. Department of Pathology, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan
3. Department of Biotechnology and Bioindustry Sciences, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, Taiwan
4. Ph.D. Program in Translational Medicine, Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Tainan, Taiwan
Interests: cytopathology; cancer immunology; molecular pathology; medical bioinformatics
Special Issue Information
Dear Colleagues,
Cytopathology is a key specialty in identifying and managing various illnesses, and recent advances have been astounding. The advancement of liquid-based cytology and molecular testing has enabled earlier and more accurate diagnoses and tailored medicines based on genetic abnormalities, improving outcomes for numerous individuals.
In addition, developing new reporting systems in cytopathology with a global agreement is a significant trend that has impacted the field. These systems strive to provide standardized terminology, criteria, and categories for cytological specimen interpretation, which can improve communication between pathologists, physicians, and patients, while also facilitating quality assurance and research.
Looking ahead, the potential for artificial intelligence and machine learning to completely transform the industry is quite remarkable. These technologies have the potential to facilitate quite a few steps that pathologists now conduct, boosting accuracy and efficiency while reducing workload. However, it is crucial to highlight that these technologies do not replace human expertise, and qualified individuals will always be required to analyze and make data-based decisions.
Overall, the area of cytopathology is primed for further advancement and innovation in the following years, with the potential to improve patient outcomes and save lives. This Special Issue, entitled "Cytopathology: Current Status and Future Prospects," aims to recruit high-quality original articles or comprehensive reviews focusing on cytopathology and advances in the following subjects:
- New insights and experience in international reporting systems;
- Application of new molecular or ancillary testing in cytopathology;
- The utilization of digital pathology;
- Rapid on-site evaluation and potential pitfalls;
- Machine learning models for cytopathology;
- Comprehensive comparison for different methods or interobserver variability.
In this Special Issue, global researchers and specialists are welcome to submit your recent research or reviews dedicated to prioritizing future medicine and promoting patient care.
Dr. Chien-Chin Chen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cytology
- diagnosis
- digital
- effusion
- fine needle aspiration
- machine learning
- molecular
- next-generation sequencing
- rapid onsite
- reporting system
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.